Table 3.
Echocardiographic parameters of LV systolic and diastolic function
NGT | IFG | IGT | Newly detected diabetes | Known diabetes | |
---|---|---|---|---|---|
n | 104 | 18 | 52 | 72 | 41 |
Systolic function | |||||
Intraventricular septum (cm) | 0.93 ± 0.19 | 0.86 ± 0.19 | 1.00 ± 0.21 | 1.03 ± 0.26* | 1.06 ± 0.19* |
LV posterior wall (cm) | 0.92 ± 0.19 | 0.86 ± 0.17 | 1.05 ± 0.20* | 1.05 ± 0.26* | 1.02 ± 0.21* |
Diastolic LV dimention (cm) | 4.49 ± 0.51 | 4.61 ± 0.38 | 4.47 ± 0.56 | 4.58 ± 0.58 | 4.44 ± 0.45 |
Systolic LV dimention (cm) | 2.74 ± 0.46 | 2.90 ± 0.37 | 2.82 ± 0.47 | 2.81 ± 0.54 | 2.63 ± 0.37 |
Relative wall thickness | 0.42 ± 0.10 | 0.37 ± 0.07 | 0.47 ± 0.11* | 0.46 ± 0.14* | 0.48 ± 0.12* |
LV end-diastolic volume (mL) | 94 ± 24 | 99 ± 20 | 93 ± 27 | 99 ± 29 | 91 ± 21 |
LV end-systolic volume (mL) | 29 ± 12 | 33 ± 11 | 31 ± 13 | 32 ± 15 | 26 ± 9 |
LV ejection fraction (%) | 69 ± 7 | 67 ± 7 | 67 ± 8 | 69 ± 10 | 71 ± 7 |
LV mass (g) | 161 ± 58 | 152 ± 56 | 186 ± 70 | 200 ± 79 | 185 ± 43 |
LV mass index (g/m2) | 101 ± 33 | 91 ± 25 | 112 ± 35 | 119 ± 45 | 118 ± 27 |
Cardiac output (L/min) | 4.25 ± 1.11 | 4.15 ± 0.99 | 4.23 ± 1.49 | 4.59 ± 1.27 | 4.43 ± 1.08 |
Cardiac index (L/min/m2) | 2.68 ± 0.73 | 2.53 ± 0.61 | 2.54 ± 0.78 | 2.74 ± 0.74 | 2.83 ± 0.68 |
Diastolic function | |||||
Left atrial dimension (cm) | 3.49 ± 0.49 | 3.58 ± 0.40 | 3.62 ± 0.39 | 3.63 ± 0.50 | 3.60 ± 0.54 |
E peak flow (cm/s) | 71 ± 24 | 65 ± 14 | 54 ± 15* | 53 ± 15* | 52 ± 13* |
A peak flow (cm/s) | 69 ± 22 | 66 ± 11 | 74 ± 17 | 71 ± 20 | 80 ± 20 |
E/A peak flow | 1.12 ± 0.44 | 1.01 ± 0.26* | 0.77 ± 0.30* | 0.80 ± 0.32* | 0.68 ± 0.19* |
Isovolumic relaxation time (ms) | 75 ± 26 | 98 ± 23* | 95 ± 29* | 93 ± 20* | 102 ± 29* |
Acceleration time (ms) | 100 ± 17 | 98 ± 19 | 102 ± 18 | 100 ± 19 | 95 ± 21 |
Deceleration time (ms) | 161 ± 36 | 173 ± 50 | 206 ± 43* | 153 ± 36 | 172 ± 39 |
FPV (cm/s) | 53 ± 11 | 51 ± 7 | 44 ± 9* | 47 ± 12* | 43 ± 11* |
Data are means ± SD.
*P < 0.05 vs. NGT by Tukey-Kramer honestly significant difference post hoc test.